Results: 2

1.
Figure 2

Figure 2. From: Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Proportion of causes of death after dUCB, MRD, MUD, and MMUD transplantation.

Claudio G. Brunstein, et al. Blood. 2010 November 25;116(22):4693-4699.
2.
Figure 1

Figure 1. From: Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Clinical outcomes. (A) LFS, (B) relapse, (C) NRM, (D) neutrophil engraftment, (E) platelet engraftment, and (F) grade 2-4 acute GVHD after dUCB, MRD, MUD, and MMUD transplantation.

Claudio G. Brunstein, et al. Blood. 2010 November 25;116(22):4693-4699.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk